-
-
-
-
-
-
-
William Blair on Vera Therapeutics (VERA): 'We believe this update has positive read-through to companies developing novel therapies for IgAN'
-
-
-
-
-
-
-
Celcuity's gedatolisib shows superior results in breast cancer trial
-
-
-
-
-
-
-
Jefferies on Mineralys Therapeutics, Inc. (MLYS): 'Historical Trends Suggests M&A Is Still Statistically Possible Before PDUFA'
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Mineralys Therapeutics, Inc. (MLYS)
-
-
-
-
-
-
-
Mineralys presents lorundrostat data for hypertension patients with kidney disease
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Unicycive Therapeutics (UNCY)
-
-
-
-
-
-
-
H.C. Wainwright Downgrades Summit Therapeutics plc (SMMT) to Neutral
-
15,418 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

